Jivan Resolves Issues with Agilent; Oncology Array Planned for Autumn | GenomeWeb

Jivan Biologics, the Berkeley, Calif.-based array company that ran afoul of Agilent Technologies in June for reselling chips manufactured by Agilent without its express permission, has resolved its issues with the life sciences giant and plans to co-release a new splice array in coming weeks, according to a company official.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.